The role of perceived stigma, stigmatization and religiosity in explaining lifetime use of illicit drugs in emerging adults
by Palamar, Joseph J., Ph.D., NEW YORK UNIVERSITY, 2010, 191 pages; 3404547

Abstract:

Illicit drug use is often associated with adverse health and legal consequences, as well as stigma, or social disapproval. Stigma can be viewed as a protective factor against drug use; however, it can also exacerbate the negative social effects experienced by users. Few studies have investigated the stigma associated with drug use in an empirical manner. This study investigated how two forms of stigma, perceived stigma and stigmatization, along with religiosity, explain lifetime drug use among a diverse sample of 1048 emerging adults (18–25 years of age) in New York City. Through a cross-sectional survey design, these factors were examined for the most commonly used illicit drugs among this age group: marijuana, powder cocaine, ecstasy, and nonmedical use of opioids (e.g., Vicodin) and amphetamine (e.g., Adderall). Odds ratios for lifetime use of each drug were modeled using age-adjusted multivariate logistic regressions.

With regard to demographic predictors, females were at half the odds for ecstasy use, and there were no effects of level of educational attainment. However, race/ethnicity was a significant predictor in many models. Specifically, compared to White respondents, Black respondents were at consistently lower odds for marijuana, cocaine and amphetamine use, and Asian American respondents were at consistently lower odds for nonmedical opioid use. Black respondents were also at lower odds for ecstasy use, but the protective effect diminished when controlling for religiosity.

High levels of exposure to users consistently increased the odds of drug use, and high levels of stigmatization consistently decreased the odds of use. Religiosity was only protective for marijuana use and perceived stigma had no effect on use. Findings suggest that stigmatization of users is a protective factor against drug use; however, this is dependent on level of exposure to users. Individuals who devalue drug users are at low odds for use, but the perception of this stigma is not a protective factor against drug use. Public health policy needs to better educate both users and non-users about the health and social consequences of drug use. Alternative protective factors for those who are non-religious and highly exposed to drug users need to be explored.

 
AdviserPerry N. Halkitis
SchoolNEW YORK UNIVERSITY
SourceDAI/B 71-06, p. , Aug 2010
Source TypeDissertation
SubjectsBehavioral sciences; Social psychology; Public health occupations education
Publication Number3404547
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3404547
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.